XML 39 R20.htm IDEA: XBRL DOCUMENT v2.4.0.8
Equity (Details Narrative) (USD $)
 0 Months Ended 9 Months Ended 0 Months Ended 0 Months Ended 0 Months Ended
Mar. 14, 2013
Apr. 27, 2012
Apr. 20, 2012
Apr. 10, 2012
Jun. 03, 2011
Sep. 30, 2013
May 10, 2013
Dec. 31, 2012
Sep. 30, 2012
Sep. 02, 2012
Jul. 24, 2012
Jun. 30, 2012
Jun. 15, 2012
Jun. 07, 2012
Apr. 25, 2012
Apr. 02, 2012
Mar. 31, 2012
Mar. 02, 2012
Feb. 03, 2012
Dec. 31, 2011
Dec. 29, 2011
Aug. 18, 2011
Jun. 30, 2011
Jun. 02, 2011
Sep. 30, 2013
2010 Stock Incentive Plan [Member]
Sep. 30, 2013
2012 Stock Incentive Plan [Member]
Feb. 09, 2012
2012 Stock Incentive Plan [Member]
Mar. 09, 2013
Advanced Access Pharmacy Services, LLC [Mmeber]
Sep. 30, 2011
Warrant [Member]
Jun. 03, 2011
Warrant [Member]
May 15, 2013
Series B Preferred Stock [Member]
Sep. 30, 2013
Series B Preferred Stock [Member]
Dec. 31, 2012
Series B Preferred Stock [Member]
Sep. 30, 2013
Series A Preferred Stock [Member]
Dec. 31, 2012
Series A Preferred Stock [Member]
May 27, 2011
Series A Preferred Stock [Member]
Jul. 03, 2013
Series C Preferred Stock [Member]
Sep. 30, 2013
Series C Preferred Stock [Member]
May 15, 2013
Series C Preferred Stock [Member]
Dec. 31, 2012
Series C Preferred Stock [Member]
Preferred stock shares designated                                               1,200,000             80,000         500     50,000  
Preferred stock conversion                                                            

In no event shall the Conversion Ratio be less than four thousand, three hundred (4,300) shares of Common Stock and in no event shall the Conversion Ratio be more than ten thousand (10,000) shares of Common Stock

                  
Conversion ratio of common stock, minimum                                                             4,300                  
Conversion ratio of common stock, maximum                                                             10,000                  
Preferred stock liquidation per share                                                             $ 30               $ 100  
Preferred stock, shares outstanding                                                               80,000 0 0 0     2,005   0
Conversion price per share of common stock, minimum                                                                             $ 0.005  
Conversion price per share of common stock, maximum                                                                             $ 0.01  
Percentage of preferred stock dividends           10.00%                                                                    
Pereferred stock redemption price per share           $ 10,000                                                                    
Fund raising from secured debt         $ 500,000                                                                      
Stock issued during period for consideration of secured debt         2,253,470                                                                      
Warrant to purchase maximum number of common stock         20,476,707                                                                      
Preferred stock, price per share         $ 10,000                                                                      
Warrants, exercise price   0.12 0.12 0.12 1.02         0.01 0.01 0.01 0.01 0.01 0.12 0.05   0.14 0.14   0.20               0.65 0.70                    
Additional payment to purchase non-convertible Preferred Stock         5,000,000                                                                      
Percentage of maximum amount funded under tranche         20.00%                                                                      
Common stock initial purchase consideration of shares                                           1,126,735                                    
Common stock consideration at fair value                                           371,823                                    
Common stock closing price per share         $ 0.70                                 $ 0.33                                    
Stock issued during period for contingent consideration, shares         1,800,000                                                                      
Stock issued during period for contingent consideration         1,260,000                                                                      
Warrants charge to operations                                             12,839,860                                  
Additional paid in capital           16,116,215   11,566,930                             470,000                                  
Deferred finance costs net                 427,073               427,073     427,073                                        
Derivative warrant liability value           $ 616,388   $ 248,368                                                                
Issuance of Series B Preferred Stock                                                         80,000                          
Stock issued for services 1,000,000 350,000 1,500,000 6,170,950                                                                 200      
Shares approved and reserved for issuance under employee benefit plan                                                 4,000,000   10,000,000                          
Number of options outstanding           367,000   722,000                                                                
Shares issed under the employee benefit plans                                                   6,170,950                            
Shares available for issuance under the employee benefit plans           3,633,000   3,278,000                                   3,829,050                            
Common stock shares issued for cash, debenture interest and warrants             2,740